Supplementation of omega 3 fatty acids improves oxidative stress in activated BV2 microglial cell line

International Journal of Food Sciences and Nutrition

Volumn 66, Issue 3, 2015, Pages 293-299

  Corsi, Lorenzo ^a   Momo Dongmo, Bendjedith ^a   Avallone, Rossella ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Nitric oxide; Peroxisome proliferator activated receptor; Reactive oxygen species; Supplement rich in PUFAs

Indexed keywords

RATTUS;

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FISH OIL; LIPOPOLYSACCHARIDE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE;

ANIMAL; BRAIN CORTEX; CELL DEATH; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; DIET SUPPLEMENTATION; DRUG EFFECTS; INFLAMMATION; MALE; METABOLISM; MICROGLIA; MOUSE; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL DEATH; CELL LINE; CELL SURVIVAL; CEREBRAL CORTEX; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISH OILS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICROGLIA; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; OXIDATIVE STRESS; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84929924129     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2014.986073     Document Type: Article

References (33)

1. Ajmone-Cat M, Lavinia Salvatori M, De Simone R, Mancini M, Biagioni S, Bernardo A, Cacci E, Minghetti L. 2012. Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells. J Neurosci Res 90:575-587.
2. Aleshin S, Reiser G. 2013. Role of the peroxisome proliferator-activated receptors (PPAR)-a, b/d and g triad in regulation of reactive oxygen species signaling in brain. Biol Chem 394:1553-1570.
3. Avallone R, Rustichelli C, Campioli E, Notarangelo FMP, Braghiroli D, Baraldi M. 2009. Alpha-Linolenic acid and Linoleic acid in serum and tissues after flaxseed (Linum usitatissimum) oil in vivo administration. J Food Lipids 16: 287-296.
4. Bazan NG. 2006. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling. Cell Mol Neurobiol 26:901-913.
5. Belayev L, Khoutorova L, Atkins KD, Eady TN, Hong S, Lu Y, Obenaus A, Bazan NG. 2011. Docosahexaenoic acid therapy of experimental ischemic stroke. Transl Stroke Res 2:33-41.
6. Bernardo A, Minghetti L. 2006. PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr Pharm Des 12: 93-109.
7. Bernardo A, Minghetti L. 2008. Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists. PPAR Res 2008:864140.
8. Brenna JT. 2002. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 5: 127-132.
9. Calder PC. 2009. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 91:791-795.
10. Calder PC. 2014. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta (in press).
11. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE. 2000. Inflammatory mechanisms in Alzheimer's disease: inhibition of betaamyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci Off J Soc Neurosci 20:558-567.
12. Crawford MA. 2006. Docosahexaenoic acid in neural signaling systems. Nutr Health 18:263-276.
13. Daynes RA, Jones DC. 2002. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748-759.
14. De Simone R, Ajmone-Cat MA, Minghetti L. 2004. Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol Neurobiol 29:197-212.
15. De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, Mongrand S, Layé S. 2008. Docosahexaenoic acid prevents lipopolysaccharideinduced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J Neurochem 105:296-307.
16. Ebert S, Weigelt K, Walczak Y, Drobnik W, Mauerer R, Hume DA, Weber BHF, Langmann T. 2009. Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration. J Neurochem 110:1863-1875.
17. Groeger AL, Cipollina C, Cole MP, Woodcock SR, Bonacci G, Rudolph TK, Rudolph V, et al. 2010. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 6:433-441.
18. Khair-El-Din T, Sicher SC, Vazquez MA, Chung GW, Stallworth KA, Kitamura K, Miller RT, Lu CY. 1996. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J Exp Med 183: 1241-1246.
19. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, et al. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferatoractivated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323.
20. McNamara RK, Carlson SE. 2006. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prost Leukot Essent Fatty Acids 75:329-349.
21. Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, et al. 2008. Electrophilic cyclopentenone neuroprostanes are antiinflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J Biol Chem 283: 19927-19935.
22. Niemoller TD, Bazan NG. 2010. Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Mediat 91:85-89.
23. Palacios-Pelaez R, Lukiw WJ, Bazan NG. 2010. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol 41:367-374.
24. Perry VH, Bolton SJ, Anthony DC, Betmouni S. 1998. The contribution of inflammation to acute and chronic neurodegeneration. Res Immunol 149:721-725.
25. Polazzi E, Contestabile A. 2002. Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci 13:221-242.
26. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, Witztum JL, et al. 1998a. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 95:7614-7619.
27. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. 1998b. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82.
28. Rustichelli C, Avallone R, Campioli E, Braghiroli D, Baraldi M. 2012. Polyunsaturated fatty acid levels in rat tissues after chronic treatment with dietetic oils. J Sci Food Agric 92:239-245.
29. Sergeeva M, Strokin M, Reiser G. 2005. Regulation of intracellular calcium levels by polyunsaturated fatty acids, arachidonic acid and docosahexaenoic acid, in astrocytes: possible involvement of phospholipase A2. Reprod Nutr Dev 45:633-646.
30. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. 1998. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252.
31. Wang JY, Wen LL, Huang YN, Chen YT, Ku MC. 2006. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 12:3521-3533.
32. Willson TM, Lambert MH, Kliewer SA. 2001. Peroxisome proliferatoractivated receptor gamma and metabolic disease. Annu Rev Biochem 70:341-367.
33. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270: 23975-23983.